Loading...
NVST
XNYS
Market cap3.67bUSD
Nov 20, Last price  
22.91USD
1D
-1.55%
1Q
-15.77%
IPO
-18.18%
Name

Envista Holdings Corp

Chart & performance

D1W1MN
XNYS:NVST chart
P/E
78.16
P/S
1.35
EPS
0.29
Vol. 1Y
39.98%
Shs. 5Y
0.61%
Rev. 5Y
7.11%
Div Yld LY
—
Div Yld TTM
—
Revenues
2.72b
+8.32%
2,785,400,0002,810,900,0002,844,500,0002,284,800,0001,929,100,0002,508,900,0002,569,100,0002,566,500,0002,510,600,0002,719,500,000
Net income
47m
P
272,000,000301,100,000230,700,000217,600,00033,299,999340,500,000243,100,000-100,200,000-1,118,600,00047,000,000
CFO
276m
-18.07%
417,000,000359,100,000400,100,000397,500,000283,900,000361,600,000182,700,000275,700,000336,500,000275,700,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.

Key people

Independent Chairman of the Board · since 2019
Paul Keel
President, Chief Executive Officer, Director · since 2024
Veronica Acurio
President - Orthodontics · since 2024
Robert Befidi
President - Diagnostics · since 2023
Stefan Nilsson
President - Nobel Biocare · since 2024
Eric Hammes
Chief Financial Officer, Senior Vice President · since 2024
Mischa Reis
Senior Vice President - Strategy and Corporate Development · since 2019
Mark Nance
Senior Vice President, General Counsel, Secretary · since 2019
Wendy Carruthers
Independent Director · since 2019
Independent Director · since 2019
Independent Director · since 2020
Independent Director · since 2025
Independent Director · since 2022
Independent Director · since 2019
IPO date
Sep 18, 2019
Employees
16,000
Domiciled in
US
Incorporated in
US
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER 1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
200 South Kraemer Boulevard
Building E
Brea, CA 92821
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT